Ars Technica

Most powerful obesity drug yet: People lost up to 25% of weight in trial

Woman using semaglutide injection pen.

Researchers published late-stage clinical trial data today for the latest obesity drug, retatrutide—expected to be the most powerful formula yet—and the results appear in line with high expectations. Patients with obesity on the highest retatrutide dose lost an average of 25 percent of their body weight after 80 weeks, and an average of 30 percent after an extension period to 104 weeks. Overall, more than a third of participants taking retatrutide lost 30 percent or more of their weight. The drug also proved effective at reducing knee pain (by up to 62 percent) in a subset of participants with…

Continue reading at Ars Technica arstechnica.com
Advertisement